Compare · BE vs TMO
BE vs TMO
Side-by-side comparison of Bloom Energy Corporation (BE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BE operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $240.87B, about 3.1x BE ($78.24B).
- Over the past year, BE is up 208.0% and TMO is up 37.2% - BE leads by 170.8 points.
- BE has been more active in the news (12 items in the past 4 weeks vs 10 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Bloom Energy Corporation
- Thermo Fisher Scientific Inc
- Price
- $265.65-5.27%
- $651.24-1.13%
- Market cap
- $78.24B
- $240.87B
- 1M return
- +28.96%
- +6.11%
- 1Y return
- +208.01%
- +37.16%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 12
- 10
- Recent ratings
- 25
- 25
Bloom Energy Corporation
Bloom Energy Corporation designs, manufactures, and sells solid-oxide fuel cell systems for on-site power generation in the United States, Japan, China, India, and the Republic of Korea. The company offers Bloom Energy Server, a power generation platform that converts standard low-pressure natural gas, biogas, or hydrogen into electricity through an electrochemical process without combustion. It serves hospitals, healthcare companies, retailers, and data centers. The company was formerly known as Ion America Corp. and changed its name to Bloom Energy Corporation in September 2006. Bloom Energy Corporation was incorporated in 2001 and is headquartered in San Jose, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BE
- Chief Commercial Officer Joshi Aman sold $972,054 worth of shares (3,601 units at $269.94) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 155,529 units (SEC Form 4) (tax liability)
- Chief Accounting Officer Kurzymski Maciej sold $616,024 worth of shares (2,295 units at $268.42), decreasing direct ownership by 3% to 77,391 units (SEC Form 4) to satisfy withholding tax
- Officer Soderberg Shawn Marie sold $775,101 worth of shares (2,870 units at $270.07) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 126,500 units (SEC Form 4) to cover taxes
- Chief Operations Officer Chitoori Satish sold $775,072 worth of shares (2,870 units at $270.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 202,494 units (SEC Form 4) (for withholding tax)
- Bloom Energy Honors Louisville First Responders During ESPN College Football Campus Tour
- SEC Form 144 filed by Bloom Energy Corporation
- Bloom Energy’s 800V DC-Native Power Can Cut Billions from AI Data Center Costs, Reduce Power Use, and Eliminate Need for Transformers
- Bloom Energy Hits the Road with ESPN College Football Campus Tour to Bring the Power Conversation to Communities Nationwide
- Newsweek Names Bloom Energy to World’s Most Trustworthy Companies List in 2026
- Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
Latest TMO
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026